Free Trial

Pelthos Therapeutics (PTHS) Institutional Ownership

Pelthos Therapeutics logo
$25.45 +0.63 (+2.54%)
As of 05/5/2026 04:10 PM Eastern

Institutional Ownership Changes (13F Filings) for Pelthos Therapeutics (NYSEAMERICAN:PTHS)

Current
Institutional Ownership
Percentage
77.96%
Number of
Institutional Buyers
(last 12 months)
9
Number of
Institutional Sellers
(last 12 months)
0
Get PTHS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Pelthos Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

PTHS Institutional Buying and Selling by Quarter

Pelthos Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/18/2026Ikarian Capital LLC255,758$7.93M0.6%+309.5%7.894%
2/18/2026Millennium Management LLC11,057$343K0.0%N/A0.341%
2/18/2026Boothbay Fund Management LLC80,680$2.50M0.0%+279.8%2.490%
2/17/2026J. Goldman & Co LP78,006$2.42M0.1%N/A2.408%
2/17/2026Cantor Fitzgerald L. P.34,990$1.09M0.0%N/A1.080%
2/17/2026Diadema Partners LP25,000$775K0.1%+138.1%0.772%
2/17/2026Persistent Asset Partners Ltd6,007$186K0.1%+150.0%0.185%
2/12/2026Knott David M Jr19,281$598K0.3%+215.5%0.595%
2/9/2026Geode Capital Management LLC13,625$422K0.0%+31.9%0.421%


PTHS Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of PTHS shares?

During the previous two years, 9 institutional investors and hedge funds held shares of Pelthos Therapeutics. The most heavily invested institutionals were Ikarian Capital LLC ($7.93M), Boothbay Fund Management LLC ($2.50M), J. Goldman & Co LP ($2.42M), Cantor Fitzgerald L. P. ($1.09M), Diadema Partners LP ($775K), Knott David M Jr ($598K), and Geode Capital Management LLC ($422K).Learn more on Pelthos Therapeutics' institutional investors.

What percentage of Pelthos Therapeutics' stock is owned by institutional investors?

77.96% of Pelthos Therapeutics' stock is owned by institutional investors. Learn more on PTHS's institutional investor holdings.

Which institutional investors have been buying Pelthos Therapeutics' stock?

Of the 9 institutional investors that purchased Pelthos Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Ikarian Capital LLC ($193.31K), J. Goldman & Co LP ($78.01K), Boothbay Fund Management LLC ($59.44K), Cantor Fitzgerald L. P. ($34.99K), Diadema Partners LP ($14.50K), Knott David M Jr ($13.17K), and Millennium Management LLC ($11.06K).

How much institutional buying is happening at Pelthos Therapeutics?

Institutional investors have bought a total of 411,365 shares in the last 24 months. This purchase volume represents approximately $0.00 in transactions.



This page (NYSEAMERICAN:PTHS) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners